C12N 2800/20
Pseudochromosomes, minichrosomosomes
C12N2800/20 (Pseudochromosomes, minichrosomosomes) appears on 239 US grants and 358 published applications in this corpus.
Search patents in C12N- Granted patents
- 239
- Published applications
- 358
- Assignees
- 163
- Inventors
- 464
- Latest grant
- 7 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 2 | 0 |
| 1997 | 4 | 0 |
| 1998 | 6 | 0 |
| 1999 | 8 | 0 |
| 2000 | 7 | 0 |
| 2001 | 3 | 1 |
| 2002 | 5 | 12 |
| 2003 | 11 | 15 |
| 2004 | 6 | 21 |
| 2005 | 4 | 16 |
| 2006 | 5 | 14 |
| 2007 | 3 | 9 |
| 2008 | 7 | 10 |
| 2009 | 9 | 8 |
| 2010 | 6 | 12 |
| 2011 | 2 | 13 |
| 2012 | 2 | 12 |
| 2013 | 4 | 20 |
| 2014 | 10 | 29 |
| 2015 | 5 | 13 |
| 2016 | 17 | 11 |
| 2017 | 11 | 12 |
| 2018 | 17 | 12 |
| 2019 | 14 | 22 |
| 2020 | 14 | 16 |
| 2021 | 13 | 24 |
| 2022 | 10 | 10 |
| 2023 | 11 | 11 |
| 2024 | 10 | 14 |
| 2025 | 6 | 13 |
| 2026 | 7 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- VHH-containing heavy chain antibody and production thereof7 Jul 2026US 12,673,984 B2Universitätsklinikum Hamburg-Eppendorf
- Humanized universal light chain mice19 May 2026US 12,628,801 B2Regeneron Pharmaceuticals, Inc.
- Genetically modified T cell receptor mice24 Mar 2026US 12,582,105 B2Regeneron Pharmaceuticals, Inc.
- Circular RNA for translation in eukaryotic cells10 Mar 2026US 12,570,996 B2Massachusetts Institute of Technology
- Non-human animals expressing pH-sensitive immunoglobulin sequences10 Feb 2026US 12,543,711 B2Regeneron Pharmaceuticals, Inc.
- Chinese hamster artificial chromosome vector or fragment thereof and mammalian-derived cell comprising the same27 Aug 2026US 2026/0250706 A1Trans Chromosomics, Inc.
- Genetically modified t cell receptor mice4 Jun 2026US 2026/0150821 A1Regeneron Pharmaceuticals, Inc.
- Humanized light chain mice7 May 2026US 2026/0123612 A1Regeneron Pharmaceuticals, Inc.
- Tcd34 And Other Markers For Identification And Sorting Of Cells And For Use As In Vivo Tracking Assistant7 May 2026US 2026/0125691 A1CarryGenes Bioengineering, LLC
- Circular RNA For Translation In Eukaryotic Cells30 Apr 2026US 2026/0117252 A1Massachusetts Institute of Technology
Most cited
By later US patents
- Ransgenic non-human animals for producing heterologous antibodies1,941US 5,545,806 AGenPharm International, Inc. · 1996
- Transgenic non-human animals capable of producing heterologous antibodies1,680US 5,633,425 AGenPharm International, Inc. · 1997
- Transgenic non-human animals for producing heterologous antibodies1,604US 5,625,126 AGenPharm International, Inc. · 1997
- Transgenic non-human animals capable of producing heterologous antibodies950US 5,770,429 AGenPharm International, Inc. · 1998
- Transgenic non-human animals for producing heterologous antibodies679US 5,814,318 AGenPharm International, Inc. · 1998